The First People's Hospital of Hefei
12
1
2
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 12 trials
8%
1 trials in Phase 3/4
0%
0 of 0 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Intracardiac Echocardiography-Guided Catheter Ablation for Premature Ventricular Contractions Originating From the Papillary Muscles
Role: collaborator
Efficacy and Safety of Dapagliflozin in Preventing Atrial Fibrillation Recurrence After Catheter Ablation
Role: collaborator
PRevention of OsTEoporotiC FracTure 2 Pilot Study
Role: collaborator
The Natural History of Chronic Pancreatitis
Role: collaborator
CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor
Role: collaborator
CAR-T Cell Immunotherapy in MUC1 Positive Solid Tumor
Role: collaborator
CAR-pNK Cell Immunotherapy for Relapsed/Refractory CD33+ AML
Role: collaborator
CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma
Role: collaborator
PCAR-119 Bridge Immunotherapy Prior to Stem Cell Transplant in Treating Patients With CD19 Positive Leukemia and Lymphoma
Role: collaborator
Phase I/II Study of Anti-Mucin1 (MUC1) CAR T Cells for Patients With MUC1+ Advanced Refractory Solid Tumor
Role: collaborator
CAR-T Cell Immunotherapy in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma
Role: collaborator
Application of Two Anti-angiogenesis Drugs Combined With Chemotherapy in Advanced Colorectal Cancer Under the Background of Precision Medical
Role: lead
All 12 trials loaded